Thursday, 31 October 2013

Greece Pharmaceuticals and Healthcare Report Q4 2013

Business Monitor International Market Research Reports
Market Reports Online XML Feed 
Acquire Clients Globally!

Attention Advertisers: What's your CPA? Have Us Acquire Additional Clients for You Utilizing International, Localized PPC on AdWords, Bing, & Facebook Exchange!
From our sponsors
Greece Pharmaceuticals and Healthcare Report Q4 2013
Oct 30th 2013, 00:00

Price: $ 1295  

BMI View: Mounting pressure from Greece's creditors has prompted the health ministry to announce further measures to reduce pharmaceutical and healthcare expenditure, reaffirming our bleak outlook for the sector going into 2014. There have been some positive developments, such as the announcement that the state budget posted a preliminary primary surplus of EUR2.6bn (US$3.5bn) for H113. However, the state has repeatedly had to bail out the national health insurer, the EOPYY, by extending it funds in order to pay off hospitals, pharmacies and pharmaceutical companies. The principal concern among drugmakers and observers is how Greece will lower its spending next year in 2014 to under EUR2bn (US$2.66bn), when it cannot manage to curtail spending below EUR2.44bn. Headline Expenditure Projection ...

Complete report details with Table of Contents and more @

Delicious Digg Evernote Facebook Google Bookmarks Google Plus LinkedIn StumbleUpon Tumblr Twitter
You are receiving this email because you subscribed to this feed at

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

No comments:

Post a Comment